| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_SHPRH_0009200 | Exon-Exon | chr6:146240484-146285233 | chr6:145919348-145964097 | 250 nt | 0.4560 |
| hsa_SHPRH_0010200 | Exon-Exon | chr6:146243799-146245982 | chr6:145922663-145924846 | 425 nt | 0.4376 |
| hsa_SHPRH_0011800 | Exon-Exon | chr6:146256043-146256299 | chr6:145934907-145935163 | 257 nt | 0.5019 |
| hsa_SHPRH_0011900 | Exon-Exon | chr6:146256043-146256577 | chr6:145934907-145935441 | 421 nt | 0.4727 |
| hsa_SHPRH_0012000 | Exon-Exon | chr6:146256043-146271526 | chr6:145934907-145950390 | 2135 nt | 0.4323 |
| hsa_SHPRH_0013500 | Exon-Exon | chr6:146266517-146276490 | chr6:145945381-145955354 | 1610 nt | 0.3981 |
| hsa_SHPRH_0014500 | Exon-Exon | chr6:146275990-146276322 | chr6:145954854-145955186 | 333 nt | 0.3483 |
| hsa_FBXO30_0000800 | Exon-Intergenic | chr6:146125508-146216113 | chr6:145804372-145894977 | 180 nt | 0.4056 |
| hsa_FBXO30_0000900 | Exon-Intergenic | chr6:146125508-146239770 | chr6:145804372-145918634 | 270 nt | 0.4074 |
| hsa_SHPRH_0000100 | Intergenic-Exon | chr6:146106726-146216113 | chr6:145785590-145894977 | 94 nt | 0.4043 |
A review of literature indicates that the circSHPRH is a tumor suppressor in brain cancer, specifically glioblastoma, where it is downregulated and its encoded SHPRH-146aa peptide inhibits glioma growth [Di Agostino et al. DOI:10.3389/fcell.2020.00389]. A review of human studies indicates that the circSHPRH is downregulated in colorectal cancer tissues and is associated with metastasis and survival, while its overexpression inhibits proliferation and cell cycle progression [Lee et al. DOI:10.1016/j.biopha.2018.12.052].